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Background: Blood cultures (BC) have a high clinical relevance and are a priority
specimen for surveillance of antimicrobial resistance. Manual BC are still most frequently
used in resource-limited settings. Data on automated BC performance in Africa are
scarce. We implemented automated BC at a surveillance site of the African Network
for improved Diagnostics, Epidemiology and Management of Common Infectious
Agents (ANDEMIA).
Methods: Between June 2017 and January 2018, pairs of automated BC
(BacT/ALERT®FA Plus) and manual BC (brain-heart infusion broth) were compared at
a University hospital in Bouaké, Côte d’Ivoire. BC were inoculated each with a target
blood volume of 10ml from the same venipuncture. Automated BC were incubated
for up to 5 days, manual BC for up to 10 days. Terminal subcultures were performed
for manual BC only. The two systems were compared regarding yield, contamination,
and turnaround time. For quality assurance, isolates were retested in a German routine
microbiological laboratory.
Results: BC sampling was increased from on average 24 BC to 63 BC per month. A
total of 337 matched pairs of BC were included. Automated BC was positive in 36.5%,
manual BC in 24.0% (p-value < 0.01), proportion of contamination was 47.9 and 43.8%,
respectively (p-value = 1.0). Turnaround time of positive BC was shortened by 2.5 days
with automated compared to manual BC (p < 0.01). Most common detected pathogens
in both systems were Klebsiella spp. (26.0%) and Staphylococcus aureus (18.2%). Most
contaminants were members of the skin flora. Retesting of 162 isolates was concordant
in 79.6% on family level.
Conclusions: Implementing automated BC in a resource-limited setting is possible
and improves microbiological diagnostic performance. Automated BC increased yield
and shortened turnaround times. Regular training and mentorship of clinicians has to
be intensified to increase number and quality of BC. Pre-analytical training to improve
diagnostic stewardship is essential when implementing a new microbiological method.
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Retesting highlighted that manual identification and antimicrobial susceptibility testing
can be of good quality and sustainable. The implementation of automated tools should be
decided individually according to economic considerations, number of samples, stable
supply chain of consumables, and technical sustainability.
Keywords: blood culture, sub-Saharan Africa, bacterial infection, laboratory automation, quality control
INTRODUCTION
In low- andmiddle-income countries (LMIC), infectious diseases
remain one of themain causes ofmorbidity andmortality. Febrile
illness is a leading cause for admission to hospitals in Africa (1).
Despite the major burden of infectious diseases, the availability
of diagnostic microbiology services for bloodstream infections
other than malaria is often limited by cost, infrastructure,
and personnel constraints. Antimicrobial resistance (AMR)
compromises the outcome of bloodstream infections and reduces
treatment options. Although reliable data on AMR in Africa
is scarce according to the World Health Organization (WHO),
the available data indicate that AMR is increasing in Africa
(2). Furthermore, second-line drugs to treat infections with
resistant bacteria are not easily accessible in all countries.
One of the five objectives of the WHO Global Action Plan
on AMR is to strengthen the knowledge and evidence base
through surveillance and research (3). WHO defines blood
cultures (BC) as a priority specimen for AMR surveillance
and it is recommended to prioritize key clinical specimens
in resource-limited settings (4, 5). WHO also highlights
diagnostic stewardship as an integral part to build up AMR
surveillance systems, defining this as the “coordinated guidance
and interventions to improve appropriate use of microbiological
diagnostics to guide therapeutic decisions” (6).
During the last two decades, automated systems with
computer-drivenmonitor of CO2 concentration for the detection
of microorganisms in BC have been developed. Comparisons of
automated BC systems to conventional manual procedures have
shown a higher sensitivity and a shorter time to positivity (7–
9). As resources are limited, manual BC is often used in African
countries (10, 11). Data on automated BC implementation in
resource-limited settings, especially in sub-Saharan Africa, are
scarce (11, 12).
To combat infectious diseases including AMR, a surveillance
system has been developed at sentinel sites in Côte d’Ivoire
among other West African countries as part of the African
Network for improved Diagnostics, Epidemiology and
Management of Common Infectious Agents (ANDEMIA,
https://www.andemia.org) (13).
Bouaké, the second largest city in Côte d’Ivoire, is located in
the central part of the country 350 kilometers north of Abidjan,
the economic and political capital and has a population of
∼700,000 inhabitants. Bouaké was the center of military and
political crises in Côte d’Ivoire, particularly from 1999 to 2011.
The University Hospital Bouaké (CHU-B), the country’s only
academic hospital outside Abidjan, had to suspend all except
the most basic medical services between 2002 and 2011. CHU-B
today has 268 beds, 27,189 admissions and 62,515 consultations
in 21 departments per year.
In 2012–2014, a study on manual BC from severely ill patients
at CHU-B showed a positivity rate of 22.5% with highest rates
in pediatrics (14). The most commonly isolated pathogen was
Klebsiella pneumoniae, followed by Salmonella enterica. In 2017,
a study on the resistance patterns of Klebsiella pneumoniae
from clinical samples at CHU-B showed that most isolates
derived from BC and that 84% produced extended spectrum
beta-lactamases (ESBL) (15). Routine BC sampling might be
hampered by shortage of resources and empiric antibiotic
treatment is often started without diagnostics. In 2016, on
average 24 BC were processed per month (16). To improve
diagnostics and to support culture-guided therapy, an automated
BC system was implemented at CHU-B in the frame of the
ANDEMIA project.
The aim of the present study was to verify automated BC in the
laboratory, to compare automated BC with manual BC regarding
proportion positive, proportion contaminated and turnaround-
times and to improve BC sampling in order to improve patient
care as well as AMR surveillance.
METHODS
We conducted a prospective laboratory study from 28 June 2017
to 18 January 2018 to implement automated BC in a resource-
limited setting. The implementation was accompanied by a 6-
week on-site mentorship period of a clinical microbiologist from
Germany and 1 week of theoretical and practical training on BC
processing and antimicrobial susceptibility testing (AST) with an
international team of experts from Burkina Faso, Côte d’Ivoire,
the Democratic Republic of Congo and Germany.
Participants
BC from consecutive patients admitted to any department
at CHU-B with self-reported fever or fever on admission
(≥38.0◦C) and suspected bloodstream infection were included
in the study. No exclusion criteria were applied. The decision
to take blood samples for culture rested solely on the
physicians’ clinical judgement. The study was imbedded in the
routine workup.
Training of Clinicians
The departments were informed about the study by the head of
the laboratory on 26 June 2017. Clinicians were instructed to
take a set of BC for automated and manual processing from each
patient above 2 years of age with an indication for BC sampling.
Training of clinicians on good practice for BC sampling was
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performed in a one-hour session by laboratory staff in the three
departments that have sent most BC. One-page job aids on how
to take a set of BC for children and adults were distributed to each
department in the hospital.
Blood Culture Processing
Automated BC were processed using the BacT/ALERT R© 3D
system (bioMérieux, Marcy L’Etoile, France). Commercially
produced BacT/ALERT R©FA bottles were used for adults above
15 years of age and BacT/ALERT R© PF bottles were used for
children below 15 years of age. In children when insufficient
blood volume was obtained and who were below three years
of age, only the BacT/ALERT R© PF bottle was inoculated.
For manual BC, commercially available BC was used for
adults and children (HIMEDIA HiCombiTM Dual Performance
Medium and HIMEDIA BHI Broth – Supplemented x/0.05%
SPS, HIMEDIA Laboratories, Mumbai, India). In case of stock-
out, self-prepared brain-heart infusion (BHI) broth (60ml for
adult and 30ml for pediatric bottles) in suitable glass bottles
was used instead. Commercially available BC media had to
be used as suitable glass bottles to be filled manually were
not sufficiently available for the increased number of samples.
Clinicians were asked to take 20ml blood from adults and
10ml from children above 2 years via syringe, and to fill a
pair of BC bottles (i.e., 10ml each in adults and 3–4 and 5–
6ml for children for automated and manual BC, respectively,
according to manufacturer’s instructions). As weighing each
bottle before and after blood sampling to measure the exact
volume of inoculated blood was not feasible in the daily routine
and would have delayed BC processing, different types of BC
bottles were weighed beforehand. Each BC bottle was weighed
after processed in the laboratory to calculate the inoculated
blood volume.
Both BC systems were processed according to the newly
revised Standard Operating Procedures (SOPs) in the laboratory.
Automated BC bottles were incubated for up to 5 days
according to manufacturer’s instructions. Manual BC bottles
were incubated at 35± 2◦C for up to 10 days with final subculture
and checked daily for turbidity or other signs of growth (e.g.,
haemolysis, pellicle formation on surface or gas production).
Positive BC were inoculated onto locally produced 5% columbia
blood agar, chocolate agar and Hektoen enteric agar, dependent
on the result of the Gram stain, and incubated at 35 ± 2◦C in
ambient or CO2-enriched air (candle jar) for 24–48 h (Bio-Rad
Laboratories Ltd., Hercules, United States of America and Oxoid
Ltd., Hampshire, United Kingdom). Identification of isolates
was done by cultural morphology, biochemical and antigenic
methods (Supplementary Figure 1). Gram stain was performed
from positive BC and from colonies on agar. Antimicrobial
susceptibility testing (AST) was done for isolated pathogenic
bacteria by Kirby-Bauer disc diffusion test using references from
the European Committee on Antimicrobial Susceptibility Testing
(EUCAST) (17). If no breakpoint for disc diffusion was available
for EUCAST (e.g., vancomycin for staphylococci), the reference
from the Clinical & Laboratory Standards Institute (CLSI M100,
31st edition) was used instead.
Data Collection
The routine laboratory request form for microbiological
investigation for BC provided to clinicians was adapted to include
information on demographics, time of sampling and antibiotic
treatment. The attending microbiologist defined the respective
recovered isolate as contaminant or pathogen individually based
on multiple criteria including identification (e.g., common skin
contaminant), number of positive BC and clinical information.
A positive BC was defined as a BC with subsequent growth
of microorganisms.
The proportion of positive BC was defined as the number of
positive BC divided by the number of all processed BC.
The proportion of contaminated BC was defined as the
number of contaminated positive BC divided by the number of
positive BC.
The proportion of BC with a false-positive signal was defined
as the number of BC that had a positive signal without
growth in subculture divided by the number of BC with that
respective information.
The turnaround-time was measured as the days from BC
sampling until the final microbiological result was available in
the laboratory.
The time-to-detection was measured as the hours from
loading the BC bottle into the machine or incubator until the BC
was flagged positive.
The time-to-analysis was measured as the hours from loading
the BC bottle into the machine or incubator until the positive BC
bottle was removed and processed.
The time-to-positivity was measured as the hours from BC
sampling until the BC was flagged positive.
Quality Assurance/Retesting of Isolates
Since CHU-B did not have an active external quality
assurance programme, an inter-laboratory comparison
was done and isolates were retested in a German routine
microbiological laboratory.
Bacterial and fungal isolates, irrespective if they were isolated
from automated and/or manual BC, were stored in ESwabs
(Copan, Brescia, Italy) at 4◦C until the end of the study and then
shipped to Berlin, Germany. They were revived on blood agar
and checked for purity. If multiple strains were isolated from
one BC, all strains were retested, accordingly. Microorganisms
were identified using matrix-assisted laser desorption ionization
time-of-flight mass spectrometry (MALDI-TOF MS, Bruker
Daltonik, Bremen, Germany; software: MBT 7854 MSP Library,
2018) or Vitek R©2 (bioMérieux, Marcy L’Etoile, France; software
version: 8.01, 2018). AST was performed using Vitek R©2 or
disc diffusion using references from EUCAST (18). Isolates
identified as Salmonella Typhi at CHU-B were excluded
from retesting in Germany for safety reasons as handling
is recommended under higher safety levels. Comparison
of identification of isolates was done stepwise regarding
family/group, genus, and species level. If species level could
not be determined using conventional methods (e.g., for non-
fermenters or coagulase-negative staphylococci), genus or group
level was counted. Family or group were defined as follows:
Non-fermenter, Enterobacterales, gram-positive rods (Bacillus
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spp.), Micrococcaceae/Staphylococcus spp., fungi, Enterococcus
spp./Streptococcus spp. Genus was defined as follows: Non-
fermenter (other than Pseudomonas spp.), Escherichia spp.,
Alcaligenes spp., Bacillus spp., Citrobacter spp., Enterobacter
spp., Enterococcus spp., Klebsiella spp., yeasts, Micrococcus
spp., Pseudomonas spp., Salmonella spp., Staphylococcus spp.,
Streptococcus spp., Stenotrophomonas spp. and Kocuria spp.
Data Analysis
All data were double-entered into the EpiData software
(EpiData Association, Odense, Denmark) (19). Analyses were
conducted using Stata version 15.1 (StataCorp, Texas, USA)
and Microsoft Excel (2010). Automated and manual BC
were compared in terms of proportion positive, proportion
contaminated, turnaround-times, recovery of different bacteria
and maintenance. If automated or manual BC bottles were
received in the laboratory only with no matching pair, they were
excluded from the comparison. Statistical differences between
automated and manual BC were calculated using McNemars
exact test, to comparemedians theWilcoxon signed-rank test was
used. A p-value below 0.05 was defined as statistically significant.
As different manual BC bottles had to be used, a subgroup
analysis of proportion positive and contaminated in different
bottles was performed using Fisher’s exact test. Interpretations of
AST from CHU-B and Germany were compared. If duplicates
from automated and manual BC were re-tested, only one isolate
was included in the analysis. If the interpretation of AST for the
same species was different in automated and manual BC, the
more resistant test was included in the analysis.
Ethics
The studies involving human participants were reviewed and
approved by Charité University Ethics Committee Berlin,
Germany (reference number: EA2/230/17) and the National
Ethics Committee for Research in Abidjan, Côte d’Ivoire
(reference number: 141/MHSP/CNER-km). Isolates were
obtained through the hospitals routine diagnostic and used for
this study.
RESULTS
Comparison of Automated and Manual BC
In total, 440 BC were sent for analysis during the study period
of 7 months. BC sampling was increased from on average 24
BC to 63 BC per month. Of those, 103 automated BC arrived
without correspondingmanual BC in the laboratory (90 pediatric
and 13 adult BC) and were subsequently removed from the final
analysis. In total, 337 pairs of automated and manual BC were
included in the analysis. The median age of patients was 31 years
(range: 0–88 years). Of 333 patients with information on sex,
53.8% of patients were male (n = 179). Of 330 patients with
information on antibiotic treatment, 191 (57.9%) had received
antibiotics before BC sampling with amedian of 3 days (range: 0–
21 days). The three most common administered antibiotics were
ceftriaxone, amoxicillin and clavulanic acid, and gentamycin.
Volumes of BC bottles varied, but were similar in automated
and manual BC. Median volume in adult BC was 10.0ml
and in pediatric BC 3.6 and 3.0ml in automated and manual
BC, respectively.
Of 337 pairs, the results of 259 (76.9%) manual and automated
BC were concordant (Table 1). Of those, 196 were negative
(75.7%), whereas 63 were positive (24.3%). In 78 discordant pairs
(23.1%), 18 BC showed growth only in manual BC (23.1%) and
60 only in automated BC (76.9%).
The proportion of positive BC was significantly higher in
automated BC (n = 123, 36.5%) than in manual BC (n = 81,
24.0%, p < 0.01, Table 2). The proportion of contaminated BC
was not significantly higher in automated BC (n = 58, 47.5%)
than in manual BC (n = 35, 43.2%, p = 1.0). The proportion of
BC that show growth with a pathogen was 23.3% in automated
BC and 15.2% in manual BC.
Subgroup analysis of different types of manual BC bottles
(commercially available vs. self-produced BC) regarding
proportion positive and proportion contaminated did not show
a significant difference (data not shown).
Automated BC showed significantly less frequently a false
positive signal: whereas 40.2% (n = 88) of manual BC signaled
positive, but no microorganisms grew in sub-culture, 5.6% (n =
10, p < 0.01) of automated BC showed a false positive signal. The
median inoculated blood volume in these false positive BC was
10 ml.
Turnaround times were shorter with automated BC than with
manual BC irrespective of the result of the BC (p< 0.01,Table 2).
The turnaround time from BC sampling until final results was
6.0 days shorter with automated BC than with manual BC. The
time from loading the BC bottle into the machine or incubator
until the positive BC was removed and analysis was started
was shortened by 3 days (69.6 h) with automated BC compared
to manual BC. For positive BC the turnaround time from BC
sampling until final result was shortened with automated BC by
2.5 days and the time from incubating the BC bottle until the start
of analysis by 76.4 h (data not shown).
The most often detected bacteria in automated and manual
BC were coagulase-negative staphylococci (n = 56/152, 36.8%);
all of those were interpreted as contaminants (Figure 1). The
most often detected pathogens were Klebsiella spp. (n =
20/152, 13.2%), Staphyloccoccus aureus (n = 14/152, 9.2%) and
Enterobacter spp. (n = 10/152, 6.6%). The detection rate was
higher with automated BC for almost all detected bacteria.
If automated BC and manual BC were both positive (n =
63), the same microorganism was identified in 82.5% (n = 52,
Figure 2). Of those, 30 microorganisms (57.7%) were interpreted
as pathogens. For 83.3% of those pathogens (n = 25), results
TABLE 1 | Summary of concordant and discordant pairs of automated BC and
manual BC, CHU-B, Côte d’Ivoire 2017–2018, N = 337.
Results Manual BC Results Automated BC
Negative Positive Total
Negative, n (%) 196 (58.2%) 60 (17.8%) 256 (76.0%)
Positive, n (%) 18 (5.3%) 63 (18.7%) 81 (24.0%)
Total, n (%) 214 (63.5%) 123 (36.5%) 337 (100%)
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TABLE 2 | Comparison of proportion positive and contaminated and turnaround-times with responding 95% Confidence Intervals (95% CI] of automated BC and manual
BC, CHU-B, Côte d’Ivoire 2017–2018, N = 337.
Variables Automated BC Manual BC Difference p-value
n Value (95% CI) n Value (95% CI)
Proportion positive in % 123 36.5 (31.3–41.9) 81 24.0 (19.6–29.0) 12.5 <0.01
Proportion contaminated in % 58 47.9 (38.8–57.2) 35 43.8 (32.7–55.3) 4.1 1.0
median TAT1 (turnaround-time) in days 332 5.0 (5.0–5.0) 331 11.0 (11.0–12.0) 6.0 <0.01
median TTP2 (time-to-positivity) in hours 112 19.7 (17.6–22.1) 69 69.2 (45.3–113.6) 49.5 <0.01
median TTD3 (time-to-detection) in hours 126 17.0 (15.6–19.2) 80 90.4 (59.0–11.7) 73.4 <0.01
median TTA4 (time-to-analysis) in hours 127 26.8 (25.2–28.0) 79 96.4 (69.2–117.0) 69.6 <0.01
1TAT: BC sampling until final result.
2TTP: BC sampling until flagged positive.
3TTD: Loading in BC machine/incubator until flagged positive.
4TTA: Loading in BC machine/incubator until removal and initial work.
FIGURE 1 | Detected bacteria with automated BC (ABC) and manual BC (MBC), CHU-B, Côte d’Ivoire 2017–2018, N = 337.
of antimicrobial susceptibility testing (AST) were available from
both, automated and manual BC including 19 Enterobacterales
and six Staphylococcus aureus isolates. Clinical interpretation of
AST results in automated and manual BC were concordant in
52.0% (n = 13); in 48.0% (n = 12), the AST of at least one
antibiotic was interpreted differently in automated and manual
BC for the same pathogen.
The subgroup analysis of discordant pairs, where the
automated BC was positive and the final result of the
corresponding manual BC was negative, revealed that in 6.7%
(4/60), the manual BC was false-positive, i.e., the BC was signaled
positive, but no microorganisms were detected in Gram stain
or subculture. In 11.1% (2/18) of discordant pairs in which the
final result of the manual BC was positive but the automated
BC was negative, the automated BC bottle was false-positive. In
discordant pairs, the median inoculated blood volume was higher
inmanual BC than in automated BC. Adult automated BC bottles
were filled with a median of 9.5ml and manual BC with 10.0ml;
pediatric automated BC bottles were filled with amedian of 3.2ml
and manual BC with 9.4 ml.
Initial and maintenance requirements for the automated and
commercially available manual BC systems varied (Table 3). In
particular, the hands-on time was reduced with automated BC
compared to manual BC. The expenses for BC bottles were also
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FIGURE 2 | Comparison of proportion positive, detected microorganism and antimicrobial susceptibility testing (AST) results for automated BC (ABC) and manual BC
(MBC), CHU-B, Côte d’Ivoire 2017–2018, N = 337.
TABLE 3 | Comparison of initial and maintenance requirements for automated and manual BC, CHU-B, Côte d’Ivoire 2017–2018.
Automated BC Manual BC
Costs of machine • Initial funding necessary • Incubator was available
Costs of BC bottles • Similar if commercially available manual BC bottles are used
Training • Intensive training and continuous mentorship of all
laboratory staff required
• Delayed incubation if staff during weekend or night shifts
are not trained in loading the machine
• Staff were already trained in manual BC
• Additional training on ventilation of bottles
• Incubation of BC bottles could be started throughout the
weekend and night
Maintenance • Technical support from manufacturer was assured
• Reliable delivery of bottles was assured
• Expert with training in troubleshooting was available in
the laboratory
• Delivery of bottles was not always reliable
• No sustainable delivery for suitable glass bottles for
self-prepared BHI broth could be established
Hands-on time • Reduced, no daily manual inspection needed
• Incubation shortened to 5 days without final sub-culture
• False-positive signals were reduced (10/178, 5.6%)
• Daily inspection for growth
• Incubation for 10 days, final sub-culture recommended
• Often false-positive signals without subsequent growth of
microorganisms (88/219, 40.2%)
similar for automated and commercially available manual BC
as we could not establish a reliable delivery chain for suitable
glass bottles for self-prepared BHI broth for the increased request
of BC.
External Quality Control - Retesting of
Isolates
Of all 440 BC (including single automated and manual BC),
269 were positive (61.1%). Of those 269 positive BC, 272
microorganisms could be recovered as in some BC multiple
bacteria were found. However, not all isolates could be stored.
Thus, in total, 228 isolates with identification at CHU-B were
sent for retesting to Germany including duplicates recovered in
corresponding automated and manual BC (Figure 3). Of those,
20 isolates could not be revived or identified. Identification using
MALDI-TOF had to be repeated 45-times (36 isolates); in 6 cases,
VITEK-2 was used for identification, but one isolate that had
been identified as Klebsiella spp. could not be identified with
automated identification tools (MALDI-TOF and VITEK R©).
Isolates that had been identified as Salmonella Typhi were
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FIGURE 3 | Retesting of isolates from blood cultures in German laboratory for quality assurance, Côte d’Ivoire and Germany 2017–2018, n = 272. *Family or group
were defined as follows: Nonfermenter, Enterobacterales, gram-positive rods (Bacillus spp.), Micrococcaceae/Staphylococcus spp., fungi, Enterococcus
spp./Streptococcus spp. **Genus was defined as follows: Nonfermenter (other than Pseudomonas spp.), Escherichia spp., Alcaligenes spp., Bacillus spp.,
Citrobacter spp., Enterobacter spp., Enterococcus spp., Klebsiella spp., yeasts, Micrococcus spp., Pseudomonas spp., Salmonella spp., Staphylococcus spp.,
Streptococcus spp., Stenotrophomonas spp. and Kocuria spp.
excluded from retesting (n = 1). In total, 208 isolates (77% of all
isolates sent for retesting) could be retested with identification
and AST. Excluding duplicates from automated and manual
BC pairs, 162 unique isolates were retested in Germany. In
29 cases, more microorganisms were found in the sample
in Germany than detected at CHU-B. Of those 162 isolates,
identification on family or group level was concordant in 79.6%
(n = 129). Differences were mostly found in isolates identified
as Staphylococcus spp. at CHU-B (n = 16/62, 25.8%). They were
identified as non-fermenters (8/16, 50.0%) or Bacillus spp. (5/16,
31.3%) in retesting. In 112 isolates (69.1%), the identification was
concordant on genus level and in 102 isolates (63.0%) concordant
on species level. Of all Staphylococcus spp. identified at CHU-B,
67.7% (n = 42/62) were concordant on species level in retesting,
whereas 59.7% (n = 40/67) of Enterobacterales were concordant
on species level. Of those 102 isolates, AST interpretation was
concordant in 77.4% of antibiotics (n = 425) in retesting.
Teicoplanin was concordant in 10% and vancomycin in 40% of
tests. Here, the AST at CHU-B was more often non-susceptible
than the AST in retesting. Eight of 10 (80.0%) Staphylococcus
aureus isolates with concordant species identification in retesting
were concordant in methicillin-susceptibility or –resistance
testing (MSSA or MRSA). One MSSA was identified as MRSA
and one MRSA was identified as MSSA in retesting. Of 42
Enterobacterales isolates, 83.3% (n = 35) were concordant in
susceptibility to third-generation cephalosporins (cefotaxime,
ceftriaxone or ceftazidime). Susceptibility to carbapenems in
Gram-negative bacilli (n = 43 tests) was concordant in 86.0%
(n = 37); of those, 36 belonged to Enterobacterales and one
to Pseudomonas aeruginosa; three isolates (Enterobacter cloacae-
complex and Klebsiella pneumoniae) that were tested susceptible
to meropenem at CHU-B were resistant upon retesting whereas
three Enterobacterales isolates that were tested intermediate were
susceptible to meropenem upon retesting.
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DISCUSSION
Our study showed that automated BC was superior to manual
BC in this resource-limited setting at a University hospital in
Côte d’Ivoire. The yield was higher and turnaround times were
shorter in automated compared to manual BC. Automated BC
enabled the laboratory to inform the clinicians 76 h earlier about
first positive BC results than with manual BC. Furthermore, our
study increased BC sampling from 24 to 63 BC per month. These
findings are in accordance with other studies in resource-limited
settings (12, 20). Additionally, the proportion of false-positive BC
and therefore the workload could be reduced with automated
BC significantly. Before considering the implementation of
automated tools in resource-limited settings, the conditions,
costs, and needs of automated vs. manual methods should
be carefully considered according to the local setting. The
proportion of BC with growth of a pathogen was high in
both, automated and manual BC, and above the targeted 5-
15% (21). This could be an indicator that still too few BC were
sampled and patients with blood stream infections were missed.
Contamination of BC was high in automated and manual BC
(48 and 43%, respectively), although clinical training on good
practice BC sampling supported our study. The proportion of
contaminated BC was higher in our study than in comparable
studies in resource-limited settings and above the targeted 3%
(20, 22–24). As most contaminants belonged to the typical flora
of the skin, we assume that contamination occurred during
sampling due to insufficient disinfection.
We found that half of the results of AST were concordant
in automated and manual BC if the same pathogen was
found. Differences affected several antibiotic classes. An internal
quality control study in Switzerland found that even in high-
resource settings 14% of samples were not accurately retested
in the same microbiological laboratory and 3% of tested
antibiotics were interpreted differently (25). By the time of the
study, internal quality controls including sterility tests were in
place, but commercially available quality control strains were
not established.
For a good quality management system the implementation
of external quality control programmes is essential (13, 26). As
no external quality control was in place at CHU-B at the time of
the study, we retested isolates in a German routine microbiology
laboratory. The comparison of manual and automated methods
for identification should be interpreted with caution as these use
different principles. The identification of microorganisms from
CHU-B posed difficulties for the automated tools in retesting
and had to be retested several times or could not be identified at
all. In some cases, more isolates were recovered in the samples
upon retesting. The additionally recovered isolates could have
been present but not discriminated at CHU-B or contamination
occurred during storage or planting. In only 11%, a different
bacterial genus was identified in retesting. This highlights
the good quality of manual identification despite the limited
resources. Manual identification did not allow discriminating
all bacteria to species level, but in resource-limited settings
grouping of bacteria according to their clinical relevancemight be
reasonable and shorten turnaround time (11, 27). No systematic
discordance between the identification tools could be identified.
The differences might partly be explained by contamination or
documentation error. Another reason might be that sheep blood
was not available for the preparation of blood agar. Human blood
discarded by blood bank had to be used instead. After the study,
the laboratory successfully introduced self-prepared sheep blood
agar sustainably. This was enabled by an expert exchange with
other sub-Saharan countries. Different AST results were found
in 23% of tested antibiotics upon retesting although the same
interpretation reference was used predominantly. EUCAST had
been implemented at CHU-B as this is a freely available reference
(17). However, differences could partly be explained by different
AST methods and references. If no EUCAST breakpoints for
disk diffusion were available, the references from the Clinical and
Laboratory Standards Institute (CLSI) were used at CHU-B. This
could explain why teicoplanin and vancomycin were interpreted
asmore resistant at CHU-B than in retesting. Inter-test variability
should also be considered to explain some of the differences.
The culture of microorganisms is influenced by many factors,
e.g., culture media, inoculation of plate, incubation atmosphere
and time or stochastic growth variability. We experienced that
the provided EUCAST learning materials were very helpful to
introduce EUCAST, but in part too sophisticated. Difficulties
implementing EUCAST in resource-limited settings is especially
hampered because defibrinated horse blood is not available for
AST of fastidious bacteria. This has been published also by others
and we recommend a low-resource adapted EUCAST version to
overcome these obstacles (4, 28).
We asked clinicians to take blood for culture whenever
they assumed a bloodstream infection, but we did not assess
how well the recommendations were followed. To increase
adherence and to avoid overloading of the laboratory capacities,
we asked clinicians for one BC pair (automated and manual)
only. If multiple BC were collected from one patient, these
were counted as multiple cases. Anaerobic sub-culture was not
available in the laboratory. For CO2-enriched cultures, a candle
jar was used. This might explain why only few streptococci were
found. Additionally, the attending microbiologist evaluated if
the recovered bacteria were defined as contaminant or pathogen
individually based on multiple criteria, not only identification.
This might lead to different results.
Our study emphasizes that the implementation of automated
tools such as BC incubation might be of value, but that
good quality manual microbiological methods for identification
and AST might not be inferior to automated processes.
Before considering the implementation of automated tools, they
should be adapted to the conditions and needs in resource-
limited settings as they are costly, require regular training and
maintenance and are not adapted to the tropical climate and
environment (11). In our study setting, the price for automated
BC bottles was higher than for BC with self-prepared BHI broth.
However, we could not establish a sustainable delivery of suitable,
reusable glass bottles for the increased BC requests. Therefore,
we had to purchase commercially available manual BC bottles,
so the price did not differ much from the price of automated
BC bottles. Moreover, the supply chain for automated BC bottles
in our study setting was more reliable. The maintenance and
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technical support of automated BC is critical. Laboratory staff
trained in troubleshooting for automated BC were available in
the laboratory throughout our study period. All microbiological
laboratory staff were trained in the loading and unloading of
automated BC stepwise. The BacT/ALERT R© 3D system was
placed in a separate and clean room with air-conditioning. We
did not experience power shortcuts with breakdown of the
machine. For sustainable implementation of automated tools,
the system has to be integrated in the laboratory strategy,
funding beyond study periods has to be assured and therefore,
all levels, including ministries of health, should be integrated in
the process.
In expert interviews conducted in Africa and Asia, all
interviewers listed environmental conditions as a significant
challenge for BC processing (29). Further challenges are
the different spectrum of “tropical” bacteria. Our study
showed that automated tools might have difficulties identifying
these bacteria. More important than implementing automated
identification and AST tools are the implementation of good
quality management systems including internal and external
quality control (27). Laboratories face huge problems as
necessary reagents for manual identification are not available
anymore. To ensure good quality manual identification it is
essential to maintain the production and delivery of these
necessary reagents.
Our study was one step to implement and improve diagnostic
stewardship at CHU-B. We were able to improve sampling
and processing of BC in the laboratory. Diagnostic stewardship
should be further strengthened and focus intensively on
sampling, specimen transport and reporting of results.
Continuous mentorship programmes including technical
support and training should be maintained. Our study was
an important step to include AST results in the local and
national AMR surveillance and enables the comparison of
BC results between different sites using either automated or
manual BC.
CONCLUSION
Automated BC could be a valuable tool for the microbiological
laboratory in resource-limited settings if the maintenance is
assured and the staff is well-trained. Automated BC was superior
to manual BC in sensitivity and timeliness. Mentorship to
improve diagnostic stewardship further should focus on BC
sampling and reporting of results. It is very important to
implement and integrate good laboratory practices to improve
manual microbiological methods for identification and AST and
to ensure availability of necessary reagents. The implementation
of automated tools should be decided individually according to
economic considerations, number of samples processed, stable
supply chain of consumables, and technical sustainability.
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